Kopran Ltd

NSE: KOPRAN · BSE: 524280 · Pharmaceuticals & Biotechnology · 34 announcements

Share price: ₹263.89
Market cap: ₹1,275 Cr
Revenue (annual): ₹681.4 Cr
Net profit (annual): ₹25.73 Cr
P/E (TTM): 32.5×Sector 43.8×
Promoter holding: 41.82%-2.60% QoQ
FII holding: 0.91%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 4 Earnings Call 3 Price Movement Clarification 2 Other Announcement 2 Management Change 2 Dividend 2 Board Meeting Date 2 Promoter Selling 1 Promoter Buying 1 Fund Raise 1 Employee Stock Options 1 Business Update 1 Annual Report 1 Annual General Meeting 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

4 Jun 2026 22:18 IST BSE

Acquisition

Kopran Acquisition

Kopran Limited shareholders and creditors approved the Scheme of Amalgamation with Kopran Laboratories Limited. The resolution passed with requisite majority during the NCLT-convened meetings.

Open announcement → Read the filing ↗